Licensing deal brings Amprion’s misfolded-protein test closer to European trial sites, aiming to speed up neurodegenerative ...

Deal with Singapore’s MuseCell Innovations could bring $300 million in business and 200 jobs to Celularity’s cell platform.

Fresh off the world’s largest mammalian longevity screen, Longevica names ex-Genentech exec Prasun Mishra to steer science ...

A newly allowed US patent covers the lipid delivery system behind Daewoong’s experimental mRNA platform for reprogramming ...

A new 10–15 minute series aims to bring clarity and nuance to the big and bold ideas shaping the future of human longevity.

Function Health now lets members feed lab results into ChatGPT, Claude and Perplexity, turning AI answers into ones grounded ...

Genesis’ engineered pig kidney kept patients off dialysis for months, including one record nine-month stretch before a ...

USPTO grant strengthens Alterity’s IP position and opens a path for ATH434 into Parkinson’s disease investment.

Longevity is becoming big business, but the science, standards and clinical practices needed to guide the field are still ...

THPharm already has a drug in late-stage trials. Now it’s using AI to work backwards and find out what else that drug might ...

Veradermics posts $819.9m war chest and full slate of late-stage trial data as it races to become first FDA-approved oral ...

One-year trial results show most patients kept off GLP-1-induced weight loss after a single endoscopic procedure.